An Endogenous Serine/Threonine Protein Phosphatase Inhibitor, G-Substrate, Reduces Vulnerability in Models of Parkinson's Disease
Chee Yeun Chung(Whitehead Institute for Biomedical Research), Ole Isacson(McLean Hospital)
Cited by 35
Related Papers
The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability
|Cell|2022|167
Proteasome Activator Enhances Survival of Huntington's Disease Neuronal Model Cells
|PLoS ONE|2007|133
The Toll-Like Receptor-3 Agonist Polyinosinic:Polycytidylic Acid Triggers Nigrostriatal Dopaminergic Degeneration
|Journal of Neuroscience|2010|101